Erratum: The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids (Cell Stem Cell (2019) 24(4) (621–636.e16), (S1934590919300724), (10.1016/j.stem.2019.02.020))

Ayesh K. Seneviratne, Mingjing Xu, Juan J. Aristizabal Henao, Val A. Fajardo, Zhenyue Hao, Veronique Voisin, G. Wei Xu, Rose Hurren, S. Kim, Neil MacLean, Xiaoming Wang, Marcela Gronda, Danny Jeyaraju, Yulia Jitkova, Troy Ketela, Michael Mullokandov, David Sharon, Geethu Thomas, Raphaël Chouinard-Watkins, James R. HawleyCaitlin Schafer, Helen Loo Yau, Zaza Khuchua, Ahmed Aman, Rima Al-awar, Atan Gross, Steven M. Claypool, Richard P. Bazinet, Mathieu Lupien, Steven Chan, Daniel D. De Carvalho, Mark D. Minden, Gary D. Bader, Ken D. Stark, Paul LeBlanc, Aaron D. Schimmer

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids (Cell Stem Cell (2019) 24(4) (621–636.e16), (S1934590919300724), (10.1016/j.stem.2019.02.020))'. Together they form a unique fingerprint.

Medicine & Life Sciences